Author:
Zhang Yuhan,Guo Hongsheng,Fu Hui
Funder
Dongguan Social Development Key Project
Guangdong Medical Research Foundation Project
Publisher
Springer Science and Business Media LLC
Reference28 articles.
1. Trist, B. G., Hare, D. J., & Double, K. L. (2019). Oxidative stress in the aging substantia nigra and the etiology of Parkinson’s disease. Aging Cell, 18, e13031.
2. Jiang, T., Sun, Q., & Chen, S. (2016). Oxidative stress: a major pathogenesis and potential therapeutic target of antioxidative agents in Parkinson’s disease and Alzheimer’s disease. Progess in Neurobiology, 147, 1–19.
3. Ding, C., Ganesvaran, G., Alty, J. E., Clissold, B. G., McColl, C. D., & Reardon, K. A., et al. (2016). Study of levodopa response in Parkinson’s disease: observations on rates of motor progression. Movement Disorders, 31, 589–592.
4. Gong, P., Deng, F., Zhang, W., Ji, J., Liu, J., & Sun, Y., et al. (2017). Tectorigenin attenuates the MPP(+)-induced SH-SY5Y cell damage, indicating a potential beneficial role in Parkinson’s disease by oxidative stress inhibition. Experimental and Therapeutic Medicine, 14, 4431–4437.
5. Cotzias, G. C., Van Woert, M. H., & Schiffer, L. M. (1967). Aromatic amino acids and modification of parkinsonism. The New England Journal of Medicine, 276, 374–379.
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献